Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction [Phase 2]
Phase 2 trial update for CSL112 in adults with moderate renal impairment and acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Shear Wave Elastography in Native Kidney Disease [NA]
A terminated clinical trial evaluating shear wave elastography in native kidney disease with results posted in 2020.
-
FDA approval · 2020-05-31FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
FDA approves a supplemental ANDA for furosemide from Solco Healthcare LLC.
-
CLINICAL_TRIALS trial_result · 2020-05-27Clinical Trial Update: A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria [Phase 2]
Phase 2 clinical trial in CKD patients with type 2 diabetes and albuminuria completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients [Phase 4]
Phase 4 clinical trial evaluating evolocumab plus ezetimibe in high-risk statin-intolerant patients undergoing hemodialysis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-21Clinical Trial Update: Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
Clinical trial assessing myocardial glucose uptake in patients with chronic kidney disease has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2020-05-21Clinical Trial Update: Recovery Time and Affecting Factors in Hemodialysis Patients
A completed clinical trial evaluating recovery time and factors affecting recovery in hemodialysis patients, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-15Clinical Trial Update: Comparing the Efficacy and Safety of Ultrasound Guided Supraclavicular Block Combined With Either Intercostobrachialor Pec 11for Creation of Surgical Brachio-basilic Fistula in Chronic Renal Failure Patients on Hemodialysis [Phase 3]
Phase 3 clinical trial comparing ultrasound-guided supraclavicular block combined with Intercostobrachial or Pec 11 for creating a brachioba…
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous [Phase 2]
Phase 2 clinical trial exploring activated charcoal to decrease blood urea, creatinine, and phosphorus in patients with chronic kidney disea…
-
CLINICAL_TRIALS research · 2020-05-12Clinical Trial Update: Stress and CKD Among African Americans [NA]
Clinical trial update related to stress and chronic kidney disease in African Americans; study completed with results posted in 2020.
-
FDA approval · 2020-05-11FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) from Takeda Pharmaceuticals America, expanding its labeling.
-
FDA approval · 2020-05-11FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Immunotherapy of Chronic Kidney Failure [Phase 2]
Phase 2 clinical trial update for immunotherapy in chronic renal failure is reported, with undefined status.
-
FDA approval · 2020-05-05FDA Approved: FARXIGA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Farxiga (dapagliflozin) from AstraZeneca, adding/ updating labeling to reflect a new indication …
-
CLINICAL_TRIALS trial_result · 2020-05-01Clinical Trial Update: Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease [Phase 3]
Phase 3 trial of oral ferric maltol for iron deficiency anemia in chronic kidney disease completed; results posted in 2020.
-
FDA label_change · 2020-04-30FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for sevelamer hydrochloride (Sanofi) resulting in changes to the product’s labeling.
-
FDA approval · 2020-04-30FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Sevelamer carbonate submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2020-04-27Clinical Trial Update: The Modification of Diet in Renal Disease Study [Phase 3]
Phase 3 update for the Modification of Diet in Renal Disease Study (MDRD) completed.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis [Phase 4]
Clinical trial update for Jinshuibao in chronic kidney disease due to glomerulonephritis (Phase 4) assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Study to Compare Palindrome vs. BioFlo DuraMax Dialysis Catheters [NA]
A terminated clinical trial comparing Palindrome versus BioFlo DuraMax dialysis catheters in chronic kidney disease; results were posted in …
-
FDA label_change · 2020-04-10FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for Sevelamer carbonate from Exelan Pharmaceuticals Inc., resulting in updated labeling.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery [Phase 4]
Phase 4 trial comparing deep versus moderate neuromuscular blockade during laparoscopic surgery; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: A Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney Disease [NA]
A completed clinical trial evaluating a primary-secondary care partnership to prevent adverse outcomes in chronic kidney disease; results po…
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease [NA]
Clinical trial assessing glycemic control in type 2 diabetes patients with late-stage chronic kidney disease has completed with results post…
-
FDA approval · 2020-03-31FDA Approved: FERRLECIT — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Ferrlecit (sodium ferric gluconate complex) submitted by Sanofi-Aventis U.S. LLC, updating label…